Desmoplastic myxoid tumor, SMARCB1-mutant: a new variant of SMARCB1-deficient tumor of the central nervous system preferentially arising in the pineal region

Virchows Arch. 2021 Oct;479(4):835-839. doi: 10.1007/s00428-020-02978-3. Epub 2021 Jan 9.

Abstract

Desmoplastic myxoid tumor (DMT), SMARCB1-mutant is a recently proposed brain tumor that occurs in the pineal region of adults. This tumor is characterized by desmoplastic stroma and various degrees of myxoid matrix. Tumor cells with low-grade morphology show polyphenotypic immunoreactivity, and rhabdoid cells are rare. We herein present a case with some uncommon features such as no myxoid stroma and slightly elevated proliferating activity. To date, knowledge on the variety of SMARCB1/INI1-deficient tumors of the central nervous system is gradually increasing, encompassing highly aggressive to slow-growing varieties. DMT, SMARCB1-mutant seems to be relatively benign, but careful attention is necessary because SMARCB1/INI1 deficiency is generally a genetic signature of concern.

Keywords: Atypical teratoid/rhabdoid tumor; DMT, SMARCB1-mutant; Myxoid stroma; Pineal region; SMARCB1-mutant.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Neoplasms / genetics
  • Chromosomal Proteins, Non-Histone / genetics
  • DNA-Binding Proteins / genetics
  • Desmoplastic Small Round Cell Tumor / genetics*
  • Desmoplastic Small Round Cell Tumor / metabolism
  • Female
  • Gene Expression / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Pineal Gland / pathology
  • Pinealoma / genetics
  • Pinealoma / pathology
  • Rhabdoid Tumor / pathology
  • SMARCB1 Protein / genetics*
  • SMARCB1 Protein / metabolism
  • Sarcoma / genetics
  • Transcription Factors / genetics
  • Transcriptome / genetics

Substances

  • Chromosomal Proteins, Non-Histone
  • DNA-Binding Proteins
  • SMARCB1 Protein
  • SMARCB1 protein, human
  • Transcription Factors